MUMBAIâ€”Ranbaxy Laboratories Ltd. said Monday that the U.S. Food and Drug Administration found possible violations at the generic-drug maker's plant in India's western state of Punjab.

Shares in the Indian company fell 5.4% in Mumbai on Monday amid the news, as FDA warnings are often followed by import bans. Ranbaxy earns more than half its...